See more : T-Mobile US, Inc. (TM5.DE) Income Statement Analysis – Financial Results
Complete financial analysis of 9342-8530 Québec Inc. (DGCRF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 9342-8530 Québec Inc., a leading company in the Medical – Specialties industry within the Healthcare sector.
- Upsales Technology AB (publ) (UPSALE.ST) Income Statement Analysis – Financial Results
- Y. T. Realty Group Limited (0075.HK) Income Statement Analysis – Financial Results
- Tropical Canning (Thailand) Public Company Limited (TC.BK) Income Statement Analysis – Financial Results
- CarTrade Tech Limited (CARTRADE.BO) Income Statement Analysis – Financial Results
- Texmaco Rail & Engineering Limited (TEXRAIL.BO) Income Statement Analysis – Financial Results
9342-8530 Québec Inc. (DGCRF)
Industry: Medical - Specialties
Sector: Healthcare
About 9342-8530 Québec Inc.
9342-8530 Québec Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada. It focuses on molecular diagnostic tests for the detection and management of cancer. The company offers PCA3 test for the diagnosis of prostate cancer; and Guanylyl Cyclase C (GCC) marker and Previstage GCC colorectal cancer staging test for colorectal cancer patients, as well as PCP, a multi marker prostate cancer test. It also provides gene expression and copy number variation analysis, mutation detection, SNP genotyping, and platform and laboratory environmental services. The company was formerly known as DiagnoCure Inc. 9342-8530 Québec Inc. was founded in 1994 and is headquartered in Quebec, Canada.
Source: https://incomestatements.info
Category: Stock Reports